| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |